Phagocytosis of synthetic particulate vaccine delivery systems to program dendritic cells.

Abstract:

:Therapeutic prospects of particulates are increasingly recognized for vaccination purposes. Compared with biologic particulates, such as live or attenuated bacterial vectors and viral vectors, synthetic particulates may be expected to ease the hurdles of quality assurance and validation in vaccine development and production and shorten the time for approval and to the market. The ability of synthetic antigen-loaded particulates to elicit strong immune responses, even with low amounts of antigen and to weakly immunogenic epitopes, is suggested to be due to their efficient cross-talk with the most potent antigen-presenting cells, such as dendritic cells. Moreover, the potential of particulates for intracellular delivery and directing intracellular trafficking of antigens has evolved as a promising opportunity to target the major histocompatibility complex I pathway. In summary, synthetic particulate vaccine delivery systems are likely to play an increasingly active role in enhancing or even enabling the immunostimulating effect of antigens upon direct interaction with the target cells.

journal_name

Expert Rev Vaccines

authors

Thiele L,Merkle HP,Walter E

doi

10.1586/14760584.1.2.215

keywords:

subject

Has Abstract

pub_date

2002-08-01 00:00:00

pages

215-26

issue

2

eissn

1476-0584

issn

1744-8395

pii

ERV010213

journal_volume

1

pub_type

杂志文章,评审
  • Antigens of Corynebacterium pseudotuberculosis and prospects for vaccine development.

    abstract::Corynebacterium pseudotuberculosis continues to cause considerable economic losses in ovine and caprine herds worldwide, causing caseous lymphadenitis. Nevertheless, the immunology of this disease is relatively unknown. Novel antigens may provide vaccines that are more effective and improve diagnostic methods for bett...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.8.2.205

    authors: Dorella FA,Pacheco LG,Seyffert N,Portela RW,Meyer R,Miyoshi A,Azevedo V

    更新日期:2009-02-01 00:00:00

  • Biosynthetically engineered lipopolysaccharide as vaccine adjuvant.

    abstract::Lipopolysaccharide (LPS), a dominant component of the Gram-negative bacterial outer membrane, is a strong activator of the innate immune system, and thereby an important determinant in the adaptive immune response following bacterial infection. This adjuvant activity can be harnessed following immunization with bacter...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.2015.1026808

    authors: Zariri A,van der Ley P

    更新日期:2015-06-01 00:00:00

  • Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development.

    abstract::Several subtypes of influenza A viruses with pandemic potential are endemic in bird populations throughout Asia, Africa and the Middle East, and evidence suggests that these viruses are adapting to the mammalian host. As emphasized by the high mortality rate of humans infected with H5N1 viruses, this situation present...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/erv.13.21

    authors: Barrett PN,Portsmouth D,Ehrlich HJ

    更新日期:2013-04-01 00:00:00

  • Vaccination and the TAP-independent antigen processing pathways.

    abstract::The cytotoxic CD8(+) T lymphocyte-mediated cellular response is important for the elimination of virus-infected cells and requires the prior recognition of short viral peptide antigens previously translocated to the endoplasmic reticulum by the transporter associated with antigen processing (TAP). However, individuals...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.2013.825447

    authors: López D,Lorente E,Barriga A,Johnstone C,Mir C

    更新日期:2013-09-01 00:00:00

  • Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine.

    abstract::Serogroup B Neisseria meningitidis is the leading cause of meningococcal disease in developed countries. There is currently no vaccine offering wide-ranging protection. Development of a serogroup B polysaccharide-based vaccine has been hindered by potential risks of autoantibodies that cross-react with glycosylated ho...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/erv.10.116

    authors: Bai X,Borrow R

    更新日期:2010-10-01 00:00:00

  • DNA-launched live-attenuated vaccines for biodefense applications.

    abstract::A novel vaccine platform uses DNA immunization to launch live-attenuated virus vaccines in vivo. This technology has been applied for vaccine development against positive-strand RNA viruses with global public health impact including alphaviruses and flaviviruses. The DNA-launched vaccine represents the recombinant pla...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1080/14760584.2016.1175943

    authors: Pushko P,Lukashevich IS,Weaver SC,Tretyakova I

    更新日期:2016-09-01 00:00:00

  • Glycoconjugate vaccines and immune interactions, and implications for vaccination schedules.

    abstract::Conjugate vaccines using diphtheria toxoid variant (CRM(197)), diphtheria toxoid and tetanus toxoid (TT) as carrier protein may induce immune interactions (interference or impairment as measured by lower antibody levels, or enhancement [higher antibody levels]) when coadministered with other vaccines. Immune enhanceme...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/erv.11.142

    authors: Borrow R,Dagan R,Zepp F,Hallander H,Poolman J

    更新日期:2011-11-01 00:00:00

  • A call for replicating vector prime-protein boost strategies in HIV vaccine design.

    abstract::A key challenge to HIV vaccine development is the integration of HIV proviral DNA into the host genome upon infection. Therefore, an optimal vaccine should block infection within hours of viral exposure, providing 'sterilizing immunity' at mucosal sites and in blood via potent, broadly reactive antibody to the HIV env...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.3.4.s105

    authors: Malkevitch NV,Robert-Guroff M

    更新日期:2004-08-01 00:00:00

  • Live-attenuated Shigella vaccines.

    abstract::Several live-attenuated Shigella vaccines, with well-defined mutations in specific genes, have shown great promise in eliciting significant immune responses when given orally to volunteers. These responses have been measured by evaluating antibody-secreting cells, serum antibody levels and fecal immunoglobulin A to ba...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.5.5.669

    authors: Venkatesan MM,Ranallo RT

    更新日期:2006-10-01 00:00:00

  • Vaccine profile of herpes zoster (HZ/su) subunit vaccine.

    abstract:INTRODUCTION:Herpes zoster (HZ) causes an often severe and painful rash in older people and may be complicated by prolonged pain (postherpetic neuralgia; PHN) and by dissemination in immune-compromised patients. HZ results from reactivation of latent varicella-zoster virus (VZV) infection, often associated with age-rel...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1080/14760584.2017.1329012

    authors: Cunningham AL,Heineman T

    更新日期:2017-07-01 00:00:00

  • Host immunity to Bacillus anthracis lethal factor and other immunogens: implications for vaccine design.

    abstract::Infections of humans with Bacillus anthracis are an issue with respect to the biothreat both to civilians and military personnel, infections of individuals by infected livestock in endemic regions and, recently, infections of intravenous drug users injecting anthrax-contaminated heroin. Existing vaccination regimens a...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.2015.981533

    authors: Altmann DM

    更新日期:2015-03-01 00:00:00

  • Typhoid vaccination: the Asian experience.

    abstract::The WHO has recently issued updated recommendations for the programmatic use of new-generation typhoid vaccines in high-risk areas of countries where typhoid fever is still endemic. Countries have subsequently been instructed to discuss how these recommendations can be implemented and to develop plans for targeted typ...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.7.5.547

    authors: DeRoeck D,Ochiai RL,Yang J,Anh DD,Alag V,Clemens JD

    更新日期:2008-07-01 00:00:00

  • Controlling pertussis: how can we do it? A focus on immunization.

    abstract:INTRODUCTION:Pertussis is a highly contagious disease of the respiratory tract which is caused by the bacterium Bordetella pertussis and is most severe in those <1 year of age. A vaccine against pertussis, introduced in the 1950's, led to a significant decrease in incidence of the disease, but recent increases in outbr...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1080/14760584.2018.1445530

    authors: Martinón-Torres F,Heininger U,Thomson A,Wirsing von König CH

    更新日期:2018-04-01 00:00:00

  • Stress and antibody response to vaccination: implications of animal studies for human clinical research.

    abstract::Psychological stress has been shown to be associated with poorer antibody levels following vaccination in both animals and humans, although the mechanisms underlying this relationship remain unclear. However, animal research has enabled investigation of how this relationship may be affected by the influence of individ...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.3.2.141

    authors: Burns V

    更新日期:2004-04-01 00:00:00

  • Gold nanoparticles and vaccine development.

    abstract::Mucosal vaccines constitute an advantageous immunization approach to achieve broad immunization against widespread diseases; however, improvements in this field are still required to expand their exploitation. As gold nanoparticles are biocompatible and can be easily functionalized with antigens, they have been propos...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.2015.1064772

    authors: Salazar-González JA,González-Ortega O,Rosales-Mendoza S

    更新日期:2015-01-01 00:00:00

  • Fluzone® High-Dose Influenza Vaccine.

    abstract:INTRODUCTION:Fluzone® High-Dose (IIV3-HD) is a trivalent, inactivated, split-virus influenza vaccine indicated for use in older adults (≥65 years of age). It contains 60 µg hemagglutinin of each influenza strain, which is four times the hemagglutinin content of standard-dose influenza vaccines, including Fluzone (IIV3-...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1080/14760584.2016.1254044

    authors: Robertson CA,DiazGranados CA,Decker MD,Chit A,Mercer M,Greenberg DP

    更新日期:2016-12-01 00:00:00

  • Leishmaniasis: focus on the design of nanoparticulate vaccine delivery systems.

    abstract::Although mass vaccination of the entire population of an endemic area would be the most cost-effective tool to diminish Leishmania burden, an effective vaccine is not yet commercially available. Practically, vaccines have failed to achieve the required level of protection, possibly owing to the lack of an appropriate ...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/erv.11.166

    authors: Doroud D,Rafati S

    更新日期:2012-01-01 00:00:00

  • 11th Annual Conference on Vaccine Research.

    abstract::The 11th Annual Conference on Vaccine Research, hosted by the National Foundation for Infectious Disease, attracted approximately 450 leaders in the fields of epidemiology, health economics, immunology and vaccinology, making it the largest scientific meeting devoted exclusively to vaccine research and technology. The...

    journal_title:Expert review of vaccines

    pub_type:

    doi:10.1586/14760584.7.6.721

    authors: O'Brien J

    更新日期:2008-08-01 00:00:00

  • The Ebola virus glycoprotein and its immune responses across multiple vaccine platforms.

    abstract::Introduction: For over 40 years, ebolaviruses have been responsible for sporadic outbreaks of severe and often fatal hemorrhagic fever in humans and nonhuman primates across western and central Africa. In December 2013, an unprecedented Ebola virus (EBOV) epidemic began in West Africa and resulted in the largest outbr...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1080/14760584.2020.1738225

    authors: O'Donnell K,Marzi A

    更新日期:2020-03-01 00:00:00

  • 10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.

    abstract::The global burden of disease due to Streptococcus pneumoniae remains high. The licensed 7-valent pneumococcal conjugate vaccine (7vCRM, Prevenar/Prevnar) has successfully reduced invasive disease in the USA, but serotype coverage is incomplete and some evidence suggests that serotype replacement has occurred. Recently...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/erv.09.113

    authors: Prymula R,Schuerman L

    更新日期:2009-11-01 00:00:00

  • Innate immune control of nucleic acid-based vaccine immunogenicity.

    abstract::Optimal vaccine efficacy requires not only a protective antigen, but also a strong immune activator as an adjuvant. Most viral vaccines, such as influenza vaccines and nonviral genetic vaccines (e.g., DNA vaccines), contain nucleic acids, which appear to act as essential 'built-in' adjuvants. Specific receptors, inclu...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/erv.09.57

    authors: Koyama S,Coban C,Aoshi T,Horii T,Akira S,Ishii KJ

    更新日期:2009-08-01 00:00:00

  • PREPS and L-particles: a new approach to virus-like particle vaccines.

    abstract::Conventional virus-like particles are usually composed of a single structural protein which spontaneously assembles into particles. L-particles, a little-known type of virus-like particle, are produced as part of the natural infectious process of many, if not all, alpha-herpesviruses. L-particles lack the nucleocapsid...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.1.4.427

    authors: Pardoe I,Dargan D

    更新日期:2002-12-01 00:00:00

  • Pertussis: should we improve intensive care management or vaccination strategies?

    abstract::Bordetella pertussis, responsible for one of the oldest vaccine-preventable diseases in children, has resurged in North America, Europe, Latin America and many countries around the world. Despite new recommended vaccination strategies for adolescents, pregnant women and adults, mortality is still significant in develo...

    journal_title:Expert review of vaccines

    pub_type: 评论,杂志文章

    doi:10.1586/erv.10.156

    authors: Ulloa-Gutierrez R,Boza R,Carvajal-Riggioni D,Baltodano A

    更新日期:2011-01-01 00:00:00

  • Influenza vaccination and fetal and neonatal outcomes.

    abstract::As pregnant women are considered a high-risk group for severe influenza illness, current recommendations advise vaccination of all pregnant women with inactivated influenza vaccine. Nevertheless, rates of maternal influenza vaccination have historically been low, possibly reflecting ongoing concerns about vaccine safe...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.2013.851607

    authors: Fell DB,Dodds L,MacDonald NE,Allen VM,McNeil S

    更新日期:2013-12-01 00:00:00

  • Clinical experience with the inactivated hepatitis A vaccine, Avaxim 80U Pediatric.

    abstract:INTRODUCTION:Hepatitis A, caused by hepatitis A virus (HAV), is primarily transmitted via the fecal/oral route either through ingestion of contaminated food and water or through direct contact with an infectious person. Prevalence of hepatitis A is strongly correlated with socioeconomic factors, decreasing with increas...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1080/14760584.2019.1580578

    authors: Bravo C,Mege L,Vigne C,Thollot Y

    更新日期:2019-03-01 00:00:00

  • Francisella virulence: significant advances, ongoing challenges and unmet needs.

    abstract::Francisella tularensis, the causative agent of tularemia, is an organism of concern as a potential biowarfare agent. Progress towards understanding the molecular basis of pathogenicity has been hampered by a lack of tools with which to manipulate the pathogen. However, the availability of genome sequence data for a ra...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/erv.09.114

    authors: Oyston PC,Griffiths R

    更新日期:2009-11-01 00:00:00

  • Chinese vaccine products go global: vaccine development and quality control.

    abstract::Through the continuous efforts of several generations, China has become one of the few countries in the world that is capable of independently addressing all the requirements by the Expanded Program on Immunization. Regulatory science is applied to continuously improve the vaccine regulatory system. Passing the prequa...

    journal_title:Expert review of vaccines

    pub_type: 历史文章,杂志文章,评审

    doi:10.1586/14760584.2015.1012503

    authors: Xu M,Liang Z,Xu Y,Wang J

    更新日期:2015-05-01 00:00:00

  • Vaccines against atherosclerosis.

    abstract::Atherosclerosis is the primary cause of acute myocardial infarction and stroke. It is well established that arterial inflammation in response to accumulation and oxidation of lipoproteins in the vascular wall is the major factor responsible for the development of atherosclerosis. During recent years, it has become app...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/erv.13.4

    authors: Nilsson J,Wigren M,Shah PK

    更新日期:2013-03-01 00:00:00

  • Current developments and prospects on human metapneumovirus vaccines.

    abstract:INTRODUCTION:Human metapneumovirus (hMPV) has become one of the major pathogens causing acute respiratory infections (ARI) mainly affecting young children, immunocompromised patients, and the elderly. Currently there are no licensed vaccines against this virus. Areas covered: Since the discovery of hMPV in 2001, many g...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1080/14760584.2017.1283223

    authors: Márquez-Escobar VA

    更新日期:2017-05-01 00:00:00

  • Age-related immune response to pneumococcal polysaccharide vaccination: lessons for the clinic.

    abstract::Due to distinct immunological limitations, both infants and elderly individuals are highly susceptible to Streptococcus pneumoniae. Routine immunization of children with the conjugate vaccine over the past decade has substantially reduced incidence of vaccine-serotype related invasive pneumococcal disease in both vacc...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.2015.963058

    authors: Iyer AS,Ohtola JA,Westerink MA

    更新日期:2015-01-01 00:00:00